Historical record - last NADAC effective date: 4/17/2024
Product Information
MOXIFLOXACIN 0.5% EYE DROP (VISCOUS) (TWICE DAILY) is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $41.9419 per ML under NDC 68180042101. Its NADAC has been published 5 times since Apr 17, 2024.
FDA first approved this application on May 28, 2015.
The High Outlier badge above means this manufacturer's average price in the MOXIFLOXACIN market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
5 mg/mL
Manufacturer
Lupin Pharmaceuticals Inc.NDC
68180042101
Classification
Generic
Dosage Form
SOLUTION
Route
OPHTHALMIC
Effective Date
4/17/2024
Active Ingredients
MOXIFLOXACIN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA204079FDA Approved
5/28/2015
On Market Since
2/13/2020
Pharmacological Classes
Price Statistics
The NADAC for MOXIFLOXACIN 0.5% EYE DROP (VISCOUS) (TWICE DAILY) has been published 5 times since Apr 17, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $41.9419 per ML |
|---|---|
| All-time high | $41.9419 (May 15, 2024) |
| All-time low | $41.9419 (Apr 17, 2024) |
| Median price | $41.9419 |
| Average price | $41.9419 |
| Largest weekly change | 0.0% (Apr 24, 2024) |
| Weeks tracked | 5 |
| Tracking since | Apr 17, 2024 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
0.0%
Last surveyed May 15, 2024 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the MOXIFLOXACIN market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of MOXIFLOXACIN 0.5% EYE DROP (VISCOUS) (TWICE DAILY)?
The current National Average Drug Acquisition Cost (NADAC) for MOXIFLOXACIN 0.5% EYE DROP (VISCOUS) (TWICE DAILY), manufactured by Lupin Pharmaceuticals Inc., is $41.9419 per ML (NDC 68180042101), effective May 15, 2024.
How has the price of MOXIFLOXACIN 0.5% EYE DROP (VISCOUS) (TWICE DAILY) changed over time?
Over the history we have for it, the NADAC for MOXIFLOXACIN 0.5% EYE DROP (VISCOUS) (TWICE DAILY) has held within roughly two percent of its current level. It has been tracked across 5 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for MOXIFLOXACIN 0.5% EYE DROP (VISCOUS) (TWICE DAILY)?
Since Apr 17, 2024, the NADAC for MOXIFLOXACIN 0.5% EYE DROP (VISCOUS) (TWICE DAILY) has ranged from a low of $41.9419 (Apr 17, 2024) to a high of $41.9419 (May 15, 2024), with a median of $41.9419 per ML.
Are there cheaper alternatives to MOXIFLOXACIN 0.5% EYE DROP (VISCOUS) (TWICE DAILY)?
No other NADAC-published product currently shares the active ingredient and strength of MOXIFLOXACIN 0.5% EYE DROP (VISCOUS) (TWICE DAILY) in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures MOXIFLOXACIN 0.5% EYE DROP (VISCOUS) (TWICE DAILY)?
MOXIFLOXACIN 0.5% EYE DROP (VISCOUS) (TWICE DAILY) (NDC 68180042101) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.